GB1291661A - Sulphonylamino-pyrimidines - Google Patents

Sulphonylamino-pyrimidines

Info

Publication number
GB1291661A
GB1291661A GB03422/71A GB1342271A GB1291661A GB 1291661 A GB1291661 A GB 1291661A GB 03422/71 A GB03422/71 A GB 03422/71A GB 1342271 A GB1342271 A GB 1342271A GB 1291661 A GB1291661 A GB 1291661A
Authority
GB
United Kingdom
Prior art keywords
pyrimidines
sulphonamide
antidiabetic
sulphonylamino
benzamido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB03422/71A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of GB1291661A publication Critical patent/GB1291661A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1291661 Antidiabetic medicines BOEHRINGER MANNHEIM GmbH 6 May 1971 [9 May 1970] 13422/71 Heading A5B [Also in Division C2] Pharmaceutical preparations especially exhibiting a strong and long-lasting antidiabetic action contain sulphonamide-pyrimidines and/ or salts thereof as active ingredient, e.g. 1-(2- phenyl-ethyl)-biguanide salt of 2-(2-methoxy-5- methyl-benzamido)-N-[5-isopropoxy - pyrimidinyl-(2)]-1, 2, 3, 4-tetrahydronaphthalene-7-sulphonamide. Administration may be enterally or parenterally.
GB03422/71A 1970-05-09 1971-05-06 Sulphonylamino-pyrimidines Expired GB1291661A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702022746 DE2022746A1 (en) 1970-05-09 1970-05-09 Blood sugar lowering sulfonylaminopyrimidines and processes for their preparation

Publications (1)

Publication Number Publication Date
GB1291661A true GB1291661A (en) 1972-10-04

Family

ID=5770688

Family Applications (1)

Application Number Title Priority Date Filing Date
GB03422/71A Expired GB1291661A (en) 1970-05-09 1971-05-06 Sulphonylamino-pyrimidines

Country Status (5)

Country Link
AT (4) AT306737B (en)
CH (4) CH563993A5 (en)
DE (1) DE2022746A1 (en)
FR (1) FR2100641B1 (en)
GB (1) GB1291661A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2107557A1 (en) * 1971-02-17 1972-10-05 Farbwerke Hoechst AG, vormals Meister Lucius & Brüning, 6000 Frankfurt Benzenesulfonamidopyrimidines and process for their preparation
DE2152230A1 (en) * 1971-10-20 1973-04-26 Boehringer Mannheim Gmbh SULPHONYLAMINOPYRIMIDINES AND METHOD FOR PRODUCING THEREOF
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
WO2012070015A1 (en) * 2010-11-24 2012-05-31 Stemergie Biotechnology Sa Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases

Also Published As

Publication number Publication date
CH563994A5 (en) 1975-07-15
AT306738B (en) 1973-04-25
FR2100641A1 (en) 1972-03-24
AT306737B (en) 1973-04-25
DE2022746A1 (en) 1971-12-02
FR2100641B1 (en) 1975-04-18
AT306728B (en) 1973-04-25
CH563993A5 (en) 1975-07-15
CH572913A5 (en) 1976-02-27
AT307428B (en) 1973-05-25
CH563992A5 (en) 1975-07-15

Similar Documents

Publication Publication Date Title
GB1205957A (en) Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes
GB1491503A (en) Method of preventing and treating thrombosis
GB1291661A (en) Sulphonylamino-pyrimidines
GB1389128A (en) Benzoxazine derivatives their preparation and use
GB1445995A (en) Pharmaceutical preparations comprising n-4-2-5-chloro-2-metho xybenzamidoethyl-phenylsulphonyl-n-cyclohexylurea and salts thereof
GB1256849A (en)
GB1362845A (en) Benzyl alcohol derivatives
GB1259197A (en)
CA953294A (en) Preparation of 3'-4'-dideoxykanamycin b active against resistant bacteria
GB1491074A (en) Pharmaceutical compositions for reducing cardiac frequenc
ES352646A1 (en) 2,3-dihydro-1,4-benzodiazepines
GB1260939A (en) beta-HYDRAZINO-ALKANOIC ACIDS AND PROCESSES FOR THEIR PREPARATION
GB1468079A (en) Ethanolamine derivatives
IE36780L (en) Pharmaceutical preparations
IE33175L (en) Sulphonamides.
GB1250279A (en)
IE38268B1 (en) 4-ethers of 3-amino-5-sulfamoyl benzoic acids process for their mnufacture and pharmaceutical preparations containing them
GB1193438A (en) Barbituric Acid Derivatives, preparation thereof and Pharmaceutical Compositions containing them
GB1454390A (en) Nasal decongestants
GB1454872A (en) Anticonvulsant
GB1310171A (en) Pharmaceutical products for the treatment of migraine
GB1185458A (en) Salicylanilide Derivatives
GB1292745A (en) 4-alkyl-diphenylmethoxy-alkylamines and acid addition salts and pharmaceutical compositions thereof
IE33520L (en) Benzylhydrazides
IL38870A (en) Racemic and optically active 1-(2,5-dichlorophenoxy)-3-tert-butylamino-2-propanol and its salts,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee